Ascendis Pharma A/S Provides Vision 3×3 Update at 39th Annual J.P. Morgan Healthcare Conference

NEXT STORY
Nerve Shield Plus Supports Nerves Health or Fake Formula? Report by 2021.Reviews
PREV STORY
Dr. Henry Ji to Participate in the H.C. Wainwright Bioconnect 2021 Virtual Investor Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Novartis announces Oncology head to retire

Basel, December 15, 2017 - Novartis announced today that Bruno Strigini, CEO Novartis Oncology ...

author_avatar
NASDAQ Market News

ContraFect to Present at ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance

YONKERS, New York, Aug. 22, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage ...

author_avatar
NASDAQ Market News

Vital Therapies Enrolls First Subject in VTL-308

SAN DIEGO, May 23, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic ...

author_avatar
NASDAQ Market News